Coastal Bridge Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Coastal Bridge Advisors's GILD Position: Q2 2026 in Review
Coastal Bridge Advisors reduced its Gilead Sciences (GILD) stake by 0.34% in Q2 2026, selling an estimated $30.6K and leaving 68,834 shares worth $8.7M. The position accounts for 0.54% of the portfolio, ranked #42.
Coastal Bridge Advisors first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.63M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Coastal Bridge Advisors held 68,834 shares of Gilead Sciences worth $8.7M as of Q2 2026.
- Coastal Bridge Advisors sold 232 Gilead Sciences shares in Q2 2026, an estimated $30.6K.
- Gilead Sciences made up 0.54% of Coastal Bridge Advisors's portfolio in Q2 2026, its #42 holding.
- Coastal Bridge Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
- Coastal Bridge Advisors's Gilead Sciences position peaked at $9.63M in Q1 2026.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.